Why Cell Line Engineering Matters
Engineering customized cellular models helps improve assay relevance, accelerate target validation, and generate more predictive data throughout discovery. BioDuro develops engineered cell lines that support screening, mechanism-of-action studies, translational biology, and early safety assessment.
Key Benefits
- Create disease-relevant cellular models, including patient-derived mutations, to improve physiological relevance and screening outcomes.
- Build robust reporter and target engagement assays using luciferase, GFP, and pathway-specific reporters for reliable high-throughput screening.
- Enable early evaluation of efficacy, mechanism of action, and potential safety liabilities using engineered and isogenic cell models.
- Support more predictive preclinical research while reducing reliance on animal studies.
Cell Line Engineering Capabilities
- CRISPR/Cas9 Gene Editing: Gene knockout (KO), knock-in (KI), targeted insertions, and point mutation generation for customized disease models.
- Stable Gene Expression: Lentiviral and other vector-based systems for long-term gene overexpression and knockdown.
- Reporter Cell Line Development: Luciferase, GFP, and pathway-specific reporter cell lines for functional and target engagement assays.
- Custom and Ready-to-Use Cell Models: Off-the-shelf engineered cell lines for common targets, along with customized models designed to meet specific research needs.
